Buy This Entire Record For
In re Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation.
United States District Court, Seventh Circuit
June 13, 2013
IN RE: YASMIN AND YAZ (DROSPIRENONE) MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION.
Bayer HealthCare Pharmaceuticals, Inc.,  No. 3:10-cv-13178-DRH-PMF This Document Relates to: Angel Ferrell, Rebecca Franco,
Bayer HealthCare Pharmaceuticals, Inc.,  No. 3:10-cv-13240-DRH-PMF Anna Garcia,
Bayer HealthCare Pharmaceuticals, Inc.,  No. 3:10-cv-13244-DRH-PMF Whitney Ingram,
Bayer HealthCare Pharmaceuticals, Inc.,  No. 3:11-cv-10652-DRH-PMF Debbie Knight,
Bayer Corp.,  No. 3:10-cv-12903-DRH-PMF Kristy Lee,
Bayer HealthCare Pharmaceuticals, Inc.,  No. 3:10-cv-13248-DRH-PMF Angelica Lopez,
Bayer Corp.,  No. 3:10-cv-12941-DRH-PMF Melanie Lowrey,
Bayer Corp.,  No. 3:10-cv-12269-DRH-PMF Kristin Saenz,
Bayer Corp.,  No. 3:10-cv-12977-DRH-PMF Michelle Simpkins,
Bayer HealthCare Pharmaceuticals, Inc.,  No. 3:10-cv-13242-DRH-PMF Atara Stewart,
Bayer HealthCare Pharmaceuticals, Inc.,  No. 3:10-cv-13243-DRH-PMF Liz Westbrook,
Bayer HealthCare Pharmaceuticals, Inc.,  No. 3:10-cv-13247-DRH-PMF
ORDER DISMISSING WITH PREJUDICE
DAVID R. HERNDON, Chief District Judge.
This matter is before the Court on the defendant Bayer HealthCare Pharmaceuticals Inc.'s motion, pursuant to Case Management Order 12 ("CMO 12"), for an order dismissing the plaintiffs' claims, in the above-captioned matters, with prejudice for failure to comply with Plaintiff Fact Sheet ("PFS") obligations.
On March 13, 2012, Bayer HealthCare Pharmaceuticals Inc. moved to dismiss the above captioned matters without prejudice for failure to comply with PFS obligations. The Court granted the motion on May 31, 2012.
In the order dismissing the above captioned actions, the Court warned the plaintiffs that, "pursuant to CMO 12 Section E, unless plaintiffs serve defendants with a COMPLETED PFS or move to vacate the dismissal without prejudice within 60 days after entry of this Order, the Order will be converted to a Dismissal With Prejudice upon defendants' motion."
On March 28, 2013, approximately ten months after the entry of the order of dismissal without prejudice, Bayer HealthCare Pharmaceuticals Inc. filed the subject motion stating the plaintiffs are still not in compliance with their PFS obligations and asking the Court to convert the dismissals to dismissals with prejudice pursuant to Section E of CMO 12,
To date, none of the above captioned plaintiffs have taken any steps to cure their PFS deficiencies, to address the without prejudice dismissal, or to reply to the motion for dismissal with prejudice. The plaintiffs have had ample time to cure the any PFS deficiencies and avoid a with prejudice dismissal.
Having considered the motion and the relevant provisions of CMO 12 the Court ORDERS as follows:
The plaintiffs in the above captioned actions have failed to comply with their obligations pursuant to CMO 12 and more than 60 days have passed since the entry of the order of dismissal without prejudice for failure to comply with CMO 12. Accordingly, pursuant to Section E of CMO 12, the plaintiffs' complaints are hereby dismissed WITH prejudice.
Further, the Court DIRECTS the Clerk of the Court to enter judgment at ...